Home » Topics » Regulatory » Patents

Patents
RSS

BACE1 inhibitors for the treatment of cognitive disorders discovered by Janssen

Sep. 14, 2009

AstraZeneca discloses Janus kinase inhibitors for the treatment of cancer

Sep. 14, 2009

Novel oncolytic compounds claimed by Korean scientists

Sep. 14, 2009

Medivation Technologies presents novel compounds for cognitive and psychotic disorders

Sep. 10, 2009

PDE4 inhibitors and mAChRs antagonists disclosed by GSK for respiratory diseases

Sep. 10, 2009

Bristol-Myers Squibb presents SERT inhibitors and NK1 antagonists as anxiolytics

Sep. 10, 2009

S*Bio discloses PI3K and mTOR inhibitors as oncolytics

Sep. 10, 2009

AmorePacific describes TRPV1 antagonists for the treatment of pain

Sep. 10, 2009

AP-1 and NF-kappaB inhibitors in early development at Bristol-Myers Squibb

Sep. 10, 2009

Panacea Biotec discloses DPP-IV inhibitors for the treatment of type 2 diabetes

Sep. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.